Prognosis after Hospitalization for Erythroderma

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Prognosis after Hospitalization for Erythroderma. / Egeberg, Alexander; Thyssen, Jacob P; Gislason, Gunnar H; Skov, Lone.

In: Acta Dermatovenereologica, Vol. 96, No. 7, 02.11.2016, p. 959-962.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Egeberg, A, Thyssen, JP, Gislason, GH & Skov, L 2016, 'Prognosis after Hospitalization for Erythroderma', Acta Dermatovenereologica, vol. 96, no. 7, pp. 959-962. https://doi.org/10.2340/00015555-2445

APA

Egeberg, A., Thyssen, J. P., Gislason, G. H., & Skov, L. (2016). Prognosis after Hospitalization for Erythroderma. Acta Dermatovenereologica, 96(7), 959-962. https://doi.org/10.2340/00015555-2445

Vancouver

Egeberg A, Thyssen JP, Gislason GH, Skov L. Prognosis after Hospitalization for Erythroderma. Acta Dermatovenereologica. 2016 Nov 2;96(7):959-962. https://doi.org/10.2340/00015555-2445

Author

Egeberg, Alexander ; Thyssen, Jacob P ; Gislason, Gunnar H ; Skov, Lone. / Prognosis after Hospitalization for Erythroderma. In: Acta Dermatovenereologica. 2016 ; Vol. 96, No. 7. pp. 959-962.

Bibtex

@article{0e355ecdb39f4211ad649dcc700fcb88,
title = "Prognosis after Hospitalization for Erythroderma",
abstract = "Erythrodermic psoriasis (EP) and erythroderma exfoliativa (EE) are acute and potentially life-threatening inflammatory reactions. We estimated hazard ratios (HRs) of 3-year mortality following hospitalization for EP or EE compared with general population controls, patients hospitalized for psoriasis vulgaris, and toxic epidermal necrolysis (TEN), respectively. We identified 26 and 48 patients with a first-time hospitalization (1997-2010) for EP and EE, respectively (10 matched population-controls for each patient), 1,998 patients with psoriasis vulgaris, and 60 patients with TEN. During follow-up, 8 (30.8{\%}) patients with EP, 19 (39.6{\%}) patients with EE, and 34 (56.7{\%}) patients with TEN died. Compared with population-controls, adjusted HRs were 4.40 (95{\%} CI 1.66-11.70) for EP and 2.16 (1.21-3.82) for EE. Compared with psoriasis vulgaris, adjusted HRs were 1.83 (0.90-3.73) for EP, and 1.28 (1.01-1.63) for EE. The risk was significantly lower in EP (0.38 (0.16-0.91)) and in EE (0.50 (0.36-0.71)), compared with TEN. Mortality in EP and EE is high, and close follow-up is advised.",
keywords = "Aged, Denmark, Dermatitis, Exfoliative, Female, Hospitalization, Humans, Male, Middle Aged, Prognosis, Psoriasis, Stevens-Johnson Syndrome",
author = "Alexander Egeberg and Thyssen, {Jacob P} and Gislason, {Gunnar H} and Lone Skov",
year = "2016",
month = "11",
day = "2",
doi = "10.2340/00015555-2445",
language = "English",
volume = "96",
pages = "959--962",
journal = "Acta Dermatovenereologica",
issn = "0001-5555",
publisher = "Society for the Publication of Acta Dermato - Venereologica",
number = "7",

}

RIS

TY - JOUR

T1 - Prognosis after Hospitalization for Erythroderma

AU - Egeberg, Alexander

AU - Thyssen, Jacob P

AU - Gislason, Gunnar H

AU - Skov, Lone

PY - 2016/11/2

Y1 - 2016/11/2

N2 - Erythrodermic psoriasis (EP) and erythroderma exfoliativa (EE) are acute and potentially life-threatening inflammatory reactions. We estimated hazard ratios (HRs) of 3-year mortality following hospitalization for EP or EE compared with general population controls, patients hospitalized for psoriasis vulgaris, and toxic epidermal necrolysis (TEN), respectively. We identified 26 and 48 patients with a first-time hospitalization (1997-2010) for EP and EE, respectively (10 matched population-controls for each patient), 1,998 patients with psoriasis vulgaris, and 60 patients with TEN. During follow-up, 8 (30.8%) patients with EP, 19 (39.6%) patients with EE, and 34 (56.7%) patients with TEN died. Compared with population-controls, adjusted HRs were 4.40 (95% CI 1.66-11.70) for EP and 2.16 (1.21-3.82) for EE. Compared with psoriasis vulgaris, adjusted HRs were 1.83 (0.90-3.73) for EP, and 1.28 (1.01-1.63) for EE. The risk was significantly lower in EP (0.38 (0.16-0.91)) and in EE (0.50 (0.36-0.71)), compared with TEN. Mortality in EP and EE is high, and close follow-up is advised.

AB - Erythrodermic psoriasis (EP) and erythroderma exfoliativa (EE) are acute and potentially life-threatening inflammatory reactions. We estimated hazard ratios (HRs) of 3-year mortality following hospitalization for EP or EE compared with general population controls, patients hospitalized for psoriasis vulgaris, and toxic epidermal necrolysis (TEN), respectively. We identified 26 and 48 patients with a first-time hospitalization (1997-2010) for EP and EE, respectively (10 matched population-controls for each patient), 1,998 patients with psoriasis vulgaris, and 60 patients with TEN. During follow-up, 8 (30.8%) patients with EP, 19 (39.6%) patients with EE, and 34 (56.7%) patients with TEN died. Compared with population-controls, adjusted HRs were 4.40 (95% CI 1.66-11.70) for EP and 2.16 (1.21-3.82) for EE. Compared with psoriasis vulgaris, adjusted HRs were 1.83 (0.90-3.73) for EP, and 1.28 (1.01-1.63) for EE. The risk was significantly lower in EP (0.38 (0.16-0.91)) and in EE (0.50 (0.36-0.71)), compared with TEN. Mortality in EP and EE is high, and close follow-up is advised.

KW - Aged

KW - Denmark

KW - Dermatitis, Exfoliative

KW - Female

KW - Hospitalization

KW - Humans

KW - Male

KW - Middle Aged

KW - Prognosis

KW - Psoriasis

KW - Stevens-Johnson Syndrome

U2 - 10.2340/00015555-2445

DO - 10.2340/00015555-2445

M3 - Journal article

C2 - 27140225

VL - 96

SP - 959

EP - 962

JO - Acta Dermatovenereologica

JF - Acta Dermatovenereologica

SN - 0001-5555

IS - 7

ER -

ID: 173673563